Improving brain tumor diagnosis during surgery
Treatments studied
Part of Brain & nervous system, Cancer clinical trials.
This trial tests a device (CCeLL-In Vivo) that may help surgeons tell tumor from normal brain tissue during an operation, which could improve how much tumor is removed while protecting healthy brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be scheduled for brain surgery to remove a suspected tumor.
- This is for people having their first brain surgery for this tumor (not a repeat surgery).
- You must not have an active bacterial or viral infection.
- You must not have a history of allergy to Indocyanine Green (a dye sometimes used in surgery).
- You must not be allergic to iodine or taking certain medications (choleretic agents or rifampicin).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new imaging device called cCeLL that helps doctors see brain tumor tissue during surgery, making diagnosis faster and more accurate. It is for adults who are already scheduled for brain tumor removal surgery.
This trial tests a special dye called indocyanine green to help surgeons see blood flow during surgery to remove part of the colon. If you have colorectal disease and need surgery, this could help make your operation safer.
This study looks at whether a special dye used during surgery can help predict how well your vision will recover after the procedure. It may help doctors better understand the results of surgery for tumors above the pituitary gland.
This early (Phase 1) study tests whether a glowing dye called indocyanine green helps surgeons better see nervous system tumor tissue during an operation, with the goal of lowering the chance of tumor coming back locally. It’s for adults whose tumor is expected to be removable and at risk for local recurrence.
This early-stage study tests an intraoperative imaging approach called “TumorGlow” to help surgeons better identify tumor tissue during surgery. It may help improve the completeness of tumor removal and reduce the chance of recurrence in certain patients.
This trial uses a special dye called indocyanine green (ICG) during surgery to make giant cell bone tumors glow, helping doctors remove them more accurately. It may lead to better surgical outcomes for people with this tumor type.
Hear when a new Indocyanine Green trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.